Head-to-head · WeighScore
NextMeds vs TeleFirst Med
The verdict
NextMeds takes it — 66.3/100 to 57.4/100.
NextMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NextMeds | TeleFirst Med |
|---|---|---|
| WeighScore | 66.3/100 | 57.4/100 |
| Grade | C | C |
| Scorecard rank | #191 | #399 |
| Semaglutide | $129/mo (plus a separate fee, compounded) | Not disclosed |
| Tirzepatide | $179/mo (plus a separate fee, compounded) | Not disclosed |
| Coverage | All 50 states | 2 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #191 · C
Strengths
- Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
- Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
- Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
- Free, no-obligation online assessment before you pay anything
Where it loses points
- Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
- Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
- A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Graded #399 · C
Strengths
- Prescribes real brand-name GLP-1 (e.g. Ozempic/Wegovy), not compounded — appealing if you specifically want FDA-approved branded medication
- Simple $120 telehealth evaluation with a licensed doctor; no insurance hassle and no prior authorization
- You fill the prescription at your own regular pharmacy rather than waiting on a mail-order compounding pharmacy
- Also a general telehealth clinic (urgent care, chronic-condition management) if you want broader care
Where it loses points
- Only Texas and North Carolina are confirmed — not available nationwide
- The $120 is an evaluation fee; the brand-name medication is billed separately at your pharmacy and can be expensive without insurance
- Small practice (about 500 patients) with limited public detail on its clinicians and program
- No compounded or lower-cost medication option, and no medication pricing is published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.